INTERNATIONAL PATENT: QED THERAPEUTICS, INC. FILES APPLICATION FOR "INFIGRATINIB AND METABOLITES THEREOF FOR USE IN METHODS OF TREATING SKELETAL DISORDERS"

GENEVA, May 6 -- QED THERAPEUTICS, INC. (3160 Porter Dr., Suite 250PALO ALTO, California 94304) filed a patent application (PCT/US2024/052968) for "INFIGRATINIB AND METABOLITES THEREOF FOR USE IN METHODS OF TREATING SKELETAL DISORDERS" on Oct 25, 2024. With publication no. WO/2025/090870, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GE, Xue (3160 Porter Dr., Suite 250PALO ALTO, California 94304), MARTIN, David (3160 Porter Dr., Suite 250PALO ALTO, California 94304), REYES, Maribel (3160 Porter Dr., Suite 250PALO ALTO, ...